BrightView Health

BrightView Health

Services:
Facility Vaping Policy
• Vaping permitted in designated area

Pharmacotherapies

• Acamprosate (Campral®)
• Buprenorphine with naloxone
• Nicotine replacement
• Lofexidine
• Buprenorphine (extended-release, injectable)
• Buprenorphine sub-dermal implant
• Non-nicotine smoking/tobacco cessation
• Buprenorphine without naloxone
• Disulfiram
• Naltrexone (oral)
• Naltrexone (extended-release, injectable)
• Clonidine

Ancillary Services

• Social skills development
• Transportation assistance
• Early intervention for HIV
• Case management service

Assessment/Pre-treatment

• Screening for substance use
• Comprehensive substance use assessment
• Screening for mental disorders
• Screening for tobacco use
• Complete medical history/physical exam
• Outreach to persons in the community

Gender Accepted

• Female
• Male

Opioid Medications used in Treatment

• Naltrexone used in Treatment
• Buprenorphine used in Treatment

Testing

• Breathalyzer or blood alcohol testing
• STD testing
• TB screening
• HIV testing
• Drug and alcohol oral fluid testing
• Testing for Hepatitis B (HBV)
• Drug or alcohol urine screening
• Testing for Hepatitis C (HCV)

Treatment Approaches

• Substance use disorder counseling
• Cognitive behavioral therapy
• Relapse prevention
• Trauma-related counseling
• Contingency management/motivational incentives
• Anger management
• Brief intervention
• Telemedicine/telehealth therapy
• Matrix Model
• Motivational interviewing

Type of Care

• Detoxification
• Substance use treatment

Recovery Support Services

• Mentoring/peer support
• Employment counseling or training
• Housing services
• Assistance with obtaining social services

Education and Counseling Services

• Marital/couples counseling
• Group counseling
• Smoking/vaping/tobacco cessation counseling
• Hepatitis education, counseling, or support
• Individual counseling
• Health education services other than HIV/AIDS or hepatitis
• HIV or AIDS education, counseling, or support
• Substance use disorder education
• Family counseling

Payment/Insurance/Funding Accepted

• Medicaid
• Private health insurance
• Cash or self-payment
• Federal military insurance (e.g., TRICARE)
• Medicare
• State-financed health insurance plan other than Medicaid

Transitional Services

• Outcome follow-up after discharge
• Aftercare/continuing care
• Discharge Planning
• Naloxone and overdose education

Payment Assistance Available

• Sliding fee scale (fee is based on income and other factors)

Facility Operation (e.g., Private, Public)

• Private for-profit organization

Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)

• Outpatient methadone/buprenorphine or naltrexone treatment
• Regular outpatient treatment
• Outpatient
• Intensive outpatient treatment
• Outpatient detoxification

Type of Opioid Treatment

• Buprenorphine detoxification
• Maintenance service with medically supervised withdrawal after stabilization
• Federally-certified Opioid Treatment Program
• Relapse prevention with naltrexone
• Prescribes naltrexone
• Prescribes buprenorphine
• Buprenorphine maintenance

Facility Smoking Policy

• Smoking permitted in designated area

Detoxification (medical withdrawal) Services

• Methamphetamines detoxification
• Cocaine Detoxification
• Medication routinely used during detoxification
• Opioids detoxification
• Benzodiazepines Detoxification

Special Programs/Groups Offered

• Pregnant/postpartum women
• Lesbian, gay, bisexual, transgender, or queer/questioning (LGBTQ)

External Source of Medications Used for Alcohol Use Disorder Treatment

• Other contracted prescribing entity

Age Groups Accepted

• Young Adults
• Adults

Type of Alcohol Use Disorder Treatment

• This facility administers/prescribes medication for alcohol use disorder

License/Certification/Accreditation

• The Joint Commission
• Drug Enforcement Agency (DEA)
• State Substance use treatment agency
• SAMHSA certification for opioid treatment program (OTP)